217 related articles for article (PubMed ID: 30417018)
21. Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.
Wiendl H; Mitsdoerffer M; Schneider D; Melms A; Lochmuller H; Hohlfeld R; Weller M
Brain; 2003 May; 126(Pt 5):1026-35. PubMed ID: 12690043
[TBL] [Abstract][Full Text] [Related]
22. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
[TBL] [Abstract][Full Text] [Related]
23. A novel anti-human ICOSL monoclonal antibody that enhances IgG production of B cells.
Chen J; Wang F; Cai Q; Shen S; Chen Y; Hao C; Sun J
Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):125-31. PubMed ID: 23607348
[TBL] [Abstract][Full Text] [Related]
24. Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
Boggio E; Gigliotti CL; Moia R; Scotta A; Crespi I; Boggione P; De Paoli L; Deambrogi C; Garzaro M; Vidali M; Chiocchetti A; Stoppa I; Rolla R; Dianzani C; Monge C; Clemente N; Gaidano G; Dianzani U
Br J Haematol; 2022 Mar; 196(6):1369-1380. PubMed ID: 34954822
[TBL] [Abstract][Full Text] [Related]
25. Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion.
Angulo G; Zeleznjak J; Martínez-Vicente P; Puñet-Ortiz J; Hengel H; Messerle M; Oxenius A; Jonjic S; Krmpotić A; Engel P; Angulo A
Elife; 2021 Jan; 10():. PubMed ID: 33459589
[TBL] [Abstract][Full Text] [Related]
26. Blocking osteopontin-fibronectin interactions reduce extracellular fibronectin deployment and arthritic immunopathology.
Mehta BB; Sharma S; Vasishta RK; Sen RK; Sharma A; Luthra-Guptasarma M
Int Immunopharmacol; 2018 Feb; 55():297-305. PubMed ID: 29306173
[TBL] [Abstract][Full Text] [Related]
27. GV1001 immunotherapy ameliorates joint inflammation in a murine model of rheumatoid arthritis by modifying collagen-specific T-cell responses and downregulating antigen-presenting cells.
Choi IA; Choi JY; Jung S; Basri F; Park S; Lee EY
Int Immunopharmacol; 2017 May; 46():186-193. PubMed ID: 28314223
[TBL] [Abstract][Full Text] [Related]
28. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
[TBL] [Abstract][Full Text] [Related]
29. ICOS Costimulation Differentially Affects T Cells in Secondary Lymphoid Organs and Inflamed Tissues.
Van DV; Bauer L; Kroczek RA; Hutloff A
Am J Respir Cell Mol Biol; 2018 Oct; 59(4):437-447. PubMed ID: 29676593
[TBL] [Abstract][Full Text] [Related]
30. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.
Provera A; Ramavath NN; Gadipudi LL; Gigliotti CL; Boggio E; Vecchio C; Stoppa I; Rolla R; Boldorini R; Pirisi M; Smirne C; Albano E; Dianzani U; Sutti S
Front Immunol; 2023; 14():1290391. PubMed ID: 38077334
[TBL] [Abstract][Full Text] [Related]
31. Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment.
Zhang M; Lee F; Knize A; Jacobsen F; Yu S; Ishida K; Miner K; Gaida K; Whoriskey J; Chen C; Gunasekaran K; Hsu H
Clin Exp Rheumatol; 2019; 37(6):906-914. PubMed ID: 30789152
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of T-cell expansion caused by inducible costimulator/B7h costimulation blockade in direct allorecognition pathway.
Du JF; Li QY; Ji XQ; Chen G; Bai X; Zuo FY; Yu B
Transplant Proc; 2011 Dec; 43(10):3960-3. PubMed ID: 22172879
[TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis.
Nie X; Cai G; Zhang W; Wang H; Wu B; Li Q; Shen Q
Clin Immunol; 2012 Mar; 142(3):269-79. PubMed ID: 22154192
[TBL] [Abstract][Full Text] [Related]
34. ICOS ligand and IL-10 synergize to promote host-microbiota mutualism.
Landuyt AE; Klocke BJ; Duck LW; Kemp KM; Muir RQ; Jennings MS; Blum SI; Tse HM; Lee G; Morrow CD; Elson CO; Maynard CL
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753483
[TBL] [Abstract][Full Text] [Related]
35. OX40 signaling is involved in the autoactivation of CD4
Jiang J; Liu C; Liu M; Shen Y; Hu X; Wang Q; Wu J; Wu M; Fang Q; Zhang X
Arthritis Res Ther; 2017 Mar; 19(1):67. PubMed ID: 28320444
[TBL] [Abstract][Full Text] [Related]
36. Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cells in vitro.
Klingenberg R; Autschbach F; Gleissner C; Giese T; Wambsganss N; Sommer N; Richter G; Katus HA; Dengler TJ
Eur J Immunol; 2005 Jun; 35(6):1712-21. PubMed ID: 15864782
[TBL] [Abstract][Full Text] [Related]
37. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
[TBL] [Abstract][Full Text] [Related]
38. B Cell ADAM10 Controls Murine Lupus Progression through Regulation of the ICOS:ICOS Ligand Axis.
Lownik JC; Wimberly JL; Conrad DH; Martin RK
J Immunol; 2019 Feb; 202(3):664-674. PubMed ID: 30610163
[TBL] [Abstract][Full Text] [Related]
39. A signaling-enhanced chimeric receptor to activate the ICOS pathway in T cells.
Vettermann C; Victor HP; Sun Y; Plewa C; Gupta S
J Immunol Methods; 2015 Sep; 424():14-9. PubMed ID: 25956037
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated gene transfer of ICOSIg fusion protein ameliorates ongoing experimental autoimmune myocarditis.
Matsui Y; Okamoto H; Inobe M; Jia N; Shimizu T; Akino M; Sugawara T; Tezuka K; Nakayama Y; Morimoto J; Kimura C; Kon S; Miyazaki T; Kitabatake A; Uede T
Hum Gene Ther; 2003 Apr; 14(6):521-32. PubMed ID: 12718763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
